Publications
467 publications
- Date
- Relevance
-
Ofatumumab (Arzerra) for Chronic Lymphatic Leukaemia
The orphan drug ofatumumab demonstrated a high objective response in patients who are refractory for fludarabine and alemtuzumab. ...
-
Treating MS-CCSVI by cerebrospinal vein dilatation is medical science and practice
The basis for using venous angioplasty as a treatment for multiple sclerosis (MS), is the presumed pathophysiological mechanism ...
-
Aztreonam (Cayston) Summary of therapeutic value
For the treatment of adult patients with cystic fibrosis and a chronic P. aeruginosa infection, the inhalation of aztreonam has ...
-
Silodosin (Silodyx) for Lower Urinary Tract Symptoms
The intended and unintended effects of silodosin are comparable with the effects of tamsulosin, alfuzosin, doxazosin and ...
-
Ivabradine (Procoralan) Summary of therapeutic value
For patients who have stable angina pectoris and do not tolerate ßblockers or have a contraindication to ß-blockers, ivabradine ...
-
ChondroCelect for Simple cartilage defects of the femoral condyle of the knee in adults
For the treatment of adults with single cartilage defects of the femoral condyle measuring between 1-4 cm2 (ICRS III or IV), the ...
-
Mometasonfuroate (Asmanex) for the indication 'persistent asthma'
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
-
Case Management
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
-
Mexiletine for the treatment of recessive congenital myotonia
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
-
Human hepatitis B immunoglobulin (Zutectra) for the prevention of hepatitis B virus (HBV) re-infection in HBV-DNA negative patients
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.